META 3i
Alternative Names: META-03; META-3iLatest Information Update: 02 Jan 2024
At a glance
- Originator META Pharmaceuticals
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders